Your browser doesn't support javascript.
loading
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial.
Hutchings, Martin; Morschhauser, Franck; Iacoboni, Gloria; Carlo-Stella, Carmelo; Offner, Fritz C; Sureda, Anna; Salles, Gilles; Martínez-Lopez, Joaquín; Crump, Michael; Thomas, Denise N; Morcos, Peter N; Ferlini, Cristiano; Bröske, Ann-Marie E; Belousov, Anton; Bacac, Marina; Dimier, Natalie; Carlile, David J; Lundberg, Linda; Perez-Callejo, David; Umaña, Pablo; Moore, Tom; Weisser, Martin; Dickinson, Michael J.
Afiliação
  • Hutchings M; Department of Hematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.
  • Morschhauser F; Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.
  • Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Carlo-Stella C; Department of Medicine, Universitat Autònoma of Barcelona, Barcelona, Spain.
  • Offner FC; Humanitas Clinical and Research Center-IRCCS and Humanitas University, Rozzano, Italy.
  • Sureda A; Ghent University, Ghent, Belgium.
  • Salles G; Institut Català d'Oncologia-Hospitalet, Institut d'Investigació Biomedica de Bellvitge, Universitat de Barcelona, Barcelona, Spain.
  • Martínez-Lopez J; Hôpital Lyon Sud, Université Claude Bernard Lyon 1, Pierre-Bénite, France.
  • Crump M; Hospital 12 de Octubre, i+12, Complutense University, Centro Nacional de Investigaciones Oncológicas, CRIS Unit, Madrid, Spain.
  • Thomas DN; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada.
  • Morcos PN; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY.
  • Ferlini C; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY.
  • Bröske AE; Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY.
  • Belousov A; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany.
  • Bacac M; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Zurich, Switzerland.
  • Dimier N; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Zurich, Switzerland.
  • Carlile DJ; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom.
  • Lundberg L; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom.
  • Perez-Callejo D; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.
  • Umaña P; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.
  • Moore T; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Zurich, Switzerland.
  • Weisser M; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany.
  • Dickinson MJ; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany.
J Clin Oncol ; 39(18): 1959-1970, 2021 06 20.
Article em En | MEDLINE | ID: mdl-33739857
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Anticorpos Biespecíficos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Anticorpos Biespecíficos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article